These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8144436)

  • 1. In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven beta-lactams.
    Bizet C; Tekaia F; Philippon A
    J Antimicrob Chemother; 1993 Dec; 32(6):907-10. PubMed ID: 8144436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative susceptibility of Ochrobactrum anthropi, Agrobacterium tumefaciens, Alcaligenes faecalis, Alcaligenes denitrificans subsp. denitrificans, Alcaligenes denitrificans subsp. xylosidans and Bordetella bronchiseptica against 35 antibiotics including 17 beta-lactams].
    Bizet C; Bizet J
    Pathol Biol (Paris); 1995 Apr; 43(4):258-63. PubMed ID: 7567111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 40 antimicrobial agents.
    Rolston KV; Messer M
    J Antimicrob Chemother; 1990 Dec; 26(6):857-60. PubMed ID: 2081727
    [No Abstract]   [Full Text] [Related]  

  • 4. Two resistance phenotypes to beta-lactams of Alcaligenes denitrificans subsp. xylosoxydans in relation to beta-lactamase types.
    Philippon A; Mensah K; Fournier G; Freney J
    J Antimicrob Chemother; 1990 Apr; 25(4):698-700. PubMed ID: 2351630
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characterization of Alcaligenes species using analysis of esterase electrophoretic polymorphism and analysis of antibiotic resistance profiles].
    Bizet C; Picard B; Philippon A; Goullet P
    Pathol Biol (Paris); 1992 May; 40(5):591-8. PubMed ID: 1495848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.
    Glupczynski Y; Hansen W; Freney J; Yourassowsky E
    Antimicrob Agents Chemother; 1988 Feb; 32(2):276-8. PubMed ID: 3163242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones.
    Tanaka G; Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1999; 45(1):28-36. PubMed ID: 9876207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The genus Alcaligenes faecalis and its implication in infectious pathology].
    Bergner E; Mărgineanu C
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(3):231-7. PubMed ID: 5035829
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L; Chen Y; Tabibi S; San Gabriel P; Zhou J; Liu Z; Lai L; Whittier S
    J Clin Microbiol; 2001 Nov; 39(11):3942-5. PubMed ID: 11682511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM; Lee GC; Ellis ME
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
    Molinari G; Schito GC
    Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility as a diagnostic aid in the identification of nonfermenting gram-negative bacteria.
    Gilardi GL
    Appl Microbiol; 1971 Nov; 22(5):821-3. PubMed ID: 5132093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance of Acinetobacter calcoaceticus strains isolated from patients treated in intensive care units.
    Kiss L; Leskó T; Széll M
    Acta Microbiol Immunol Hung; 1995; 42(4):381-7. PubMed ID: 8689090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Gram-negative bacteria to aminoglycoside antibiotics].
    Dzierzanowska D
    Pol Tyg Lek; 1977 Sep; 32(39):1497-9. PubMed ID: 917894
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
    Uete T; Matsuo K; Uete G
    Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
    Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
    Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.
    Neu HC
    Drugs; 1993; 45 Suppl 3():54-8. PubMed ID: 7689452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
    Croize J; Gout JP; Robert J; Le Noc P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance among gram-negative bacilli to newer aminoglycosides and beta-lactams.
    Jain S; Sarkar R
    Indian J Pathol Microbiol; 1991 Oct; 34(4):280-7. PubMed ID: 1818033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.